Group 1 - The company, together with Tong Youzhi, has signed an agreement with the seller KT International Investment Limited for the sale of 20.673 million shares, representing approximately 4.62% of the issued share capital, at a price of HKD 2.08 per share [2] - The seller will also subscribe for new shares of the company at the same price of HKD 2.08 per share, with the same quantity of 20.673 million shares [2] - The placement and subscription will account for approximately 4.42% of the company's enlarged issued share capital, with the subscription price reflecting a discount of about 18.75% compared to the closing price of HKD 2.56 on July 31, 2025 [2] - The expected net proceeds from the subscription are approximately HKD 40.34 million, which the company plans to use for general working capital and business operations [2]
开拓药业-B拟配售2067.3万股 净筹约4034万港元